Voloridge Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,088
Closed -$485K 1328
2023
Q3
$485K Sell
8,088
-8,123
-50% -$487K ﹤0.01% 1215
2023
Q2
$1.17M Sell
16,211
-8,045
-33% -$580K 0.01% 1093
2023
Q1
$1.78M Buy
24,256
+11,628
+92% +$855K 0.01% 1004
2022
Q4
$844K Buy
+12,628
New +$844K ﹤0.01% 1170
2021
Q4
Sell
-18,834
Closed -$1.64M 1718
2021
Q3
$1.64M Sell
18,834
-66,933
-78% -$5.82M 0.01% 1119
2021
Q2
$7.02M Sell
85,767
-47,410
-36% -$3.88M 0.05% 521
2021
Q1
$12.7M Buy
133,177
+94,888
+248% +$9.02M 0.09% 288
2020
Q4
$2.38M Buy
38,289
+23,437
+158% +$1.45M 0.02% 670
2020
Q3
$883K Sell
14,852
-18,976
-56% -$1.13M 0.01% 974
2020
Q2
$2.36M Sell
33,828
-32,369
-49% -$2.26M 0.03% 566
2020
Q1
$3M Buy
66,197
+30,992
+88% +$1.41M 0.09% 255
2019
Q4
$2.29M Sell
35,205
-20,722
-37% -$1.35M 0.04% 457
2019
Q3
$3.47M Buy
55,927
+11,873
+27% +$737K 0.06% 326
2019
Q2
$3.14M Buy
44,054
+10,806
+33% +$769K 0.09% 247
2019
Q1
$2.61M Sell
33,248
-31,879
-49% -$2.5M 0.08% 248
2018
Q4
$5.51M Buy
+65,127
New +$5.51M 0.25% 108
2018
Q3
Sell
-62,604
Closed -$8.09M 394
2018
Q2
$8.09M Buy
62,604
+5,957
+11% +$770K 0.22% 110
2018
Q1
$5.84M Buy
+56,647
New +$5.84M 0.14% 135
2017
Q4
Sell
-26,918
Closed -$2.29M 550
2017
Q3
$2.29M Buy
+26,918
New +$2.29M 0.05% 262
2016
Q3
Sell
-71,723
Closed -$5.34M 289
2016
Q2
$5.34M Buy
+71,723
New +$5.34M 0.15% 134